Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole|DRUG: Tamoxifen|DRUG: Toremifene
Sponsor: Peking Union Medical College Hospital